Company News 30 Oct 2025 Professor Minghao Zheng elected Fellow of the Australian Academy of Health and Medical Sciences  Professor Minghao Zheng, Orthocell’s Co-Founder and Chief Scientific Officer, has been elected as a Fellow of the Australian Academy of… Orthocell
Company News 29 Oct 2025 Orthocell Appoints Exclusive Remplirâ„¢ Distributor for Hong Kong Orthocell has appointed medical device distributor MontsMed as its exclusive in-country distributor for Remplir in the key Asian market of… Orthocell
Company News 20 Oct 2025 Orthocell secures global distribution rights to innovative bone regeneration technology Orthocell has signed Memorandum of Understanding to increase its equity stake in Marine Biomedical - from 1.7% to 12.0% for… Orthocell
Company News 17 Oct 2025 $30.0 Million Placement to Accelerate Global Commercialisation and Advance Product Portfolio Orthocell has today announced that it has received firm commitments for a $30 million capital raising via an institutional placement. Orthocell
Company News 10 Oct 2025 Quarterly Report – period ended 30 September 2025 Orthocell has today released its Quarterly Report for the period ended 30 September 2025, outlining a period of continued growth… Orthocell
Company News 02 Oct 2025 Orthocell Announces Record Revenue of $3m for September Quarter Orthocell has announced record quarterly revenue of $3.0 million for the September quarter – our sixth consecutive quarter of record… Orthocell
